Literature DB >> 2004617

Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2.

J A Sensibar1, M D Griswold, S R Sylvester, R Buttyan, C W Bardin, C Y Cheng, S Dudek, C Lee.   

Abstract

The rat prostate is a complex ductal system with branches and subbranches extending from one end to another. Owing to the relative distance of various regions from the urethra, the entire length of the ductal system can be divided into three segments, i.e. the proximal, intermediate, and distal segments. The present study was carried out to examine the pattern of localization of sulfated glycoprotein-2 (SGP-2), a marker protein associated with programmed cell death, in various regions of the prostatic ductal system under normal conditions and during castration-induced regression. SGP-2 has been considered an androgen-repressed gene product in the rat prostate and has previously been known as castration-induced protein or TRPM-2. In the normal rat prostate, immunoreactive SGP-2 was localized in epithelial cells lining the proximal segment in which signs of programmed cell death were apparent. Cells lining the distal and intermediate segments were, however, devoid of SGP-2. This observed regional variation in SGP-2 localization did not support an earlier hypothesis which stated that SGP-2 was constitutively expressed by all prostatic epithelial cells in the normal rat prostate. After castration in adult rats, there was a shift in the location of cells containing SGP-2 from the proximal segment toward the distal segment. Therefore, there is a regional variation in the distribution of SGP-2 in the rat prostate both before and after castration in the host. These findings are likely to be associated with a regional variation in cellular responsiveness to androgen stimulation and androgen depletion in the prostatic ductal system. Results also support the view that SGP-2 localization is associated with an early manifestation of programmed cell death in the rat prostate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004617     DOI: 10.1210/endo-128-4-2091

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  The Nuclear Factor I (NFI) gene family in mammary gland development and function.

Authors:  Janice Murtagh; Finian Martin; Richard M Gronostajski
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 2.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

3.  The role of stress proteins in prostate cancer.

Authors:  Alan So; Boris Hadaschik; Richard Sowery; Martin Gleave
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

4.  Genes regulated by androgen in the rat ventral prostate.

Authors:  Z Wang; R Tufts; R Haleem; X Cai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.

Authors:  Hideaki Miyake; Kazuki Yamanaka; Mototsugu Muramaki; Isao Hara; Martin E Gleave
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

6.  Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report.

Authors:  M R Pins; J E Fiadjoe; F Korley; M Wong; A W Rademaker; B Jovanovic; T K Yoo; J M Kozlowski; A Raji; X J Yang; C Lee
Journal:  Prostate Cancer Prostatic Dis       Date:  2004       Impact factor: 5.554

7.  Clusterin gene expression in the rat thymus is not modulated by dexamethasone treatment.

Authors:  L E French; A P Sappino; J Tschopp; J A Schifferli
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

8.  Gene expression changes are age-dependent and lobe-specific in the brown Norway rat model of prostatic hyperplasia.

Authors:  Carlise R Bethel; Jaideep Chaudhary; Matthew D Anway; Terry R Brown
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

9.  Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus.

Authors:  L E French; A P Sappino; J Tschopp; J A Schifferli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Differential age-associated regulation of clusterin expression in prostate lobes of brown Norway rats.

Authors:  Josephat Omwancha; Matthew D Anway; Terry R Brown
Journal:  Prostate       Date:  2009-02-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.